The imperial Hofburg Palace in Vienna was the setting for a special award ceremony on 12 March – during Brain Awareness Week – to recognise the outstanding creative approach of Austrian school pupils to promoting brain health in the Brain Health School Challenge.

EAN President-Elect, Elena Moro shares her plan for the future of neurology and highlights current key events and activities.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for March 2024.

Our Paper of the month for March is a retrospective longitudinal study emphasizing the important role of cortical myelin dynamics in determining neurodegeneration and clinical progression in MS.

The Lundbeck Foundation has announced the recipients of The Brain Prize 2024, the world’s largest award for outstanding contributions to neuroscience.

Submit an essay on one of the two subjects below and you will have a chance to win a travel grant to the Congress, present your paper at the Scientific Theatre (on-site) and receive a certificate.

Following the election of the next EAN Board, we are asking for expressions of interest to join our committees and working groups.

Report on an EAN Research Fellowship at the Neuropathology Department, University of Gottingen

Report on an EAN Research Fellowship at University Children's Hospital, Inselspital, Bern

The call is now open for the nomination of candidates for the EAN Board Election 2024.

The European Academy of Neurology has published a strategic neurological research agenda as a position paper in the European Journal of Neurology, to address current gaps and set priority areas for new clinically relevant research.

EAN President Paul Boon on the new all-time abstract submission record set for EAN 2024, and news of major recent and upcoming events.

Reports from two EAN Clinical Fellowship participants on their experiences in Innsbruck (AT) and London.

Our paper of the month for February is an open-label extension study to assess the long-term efficacy and safety of cerliponase in padiatric patients with CLN2 disease.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for February 2024.